Wednesday, February 10, 2010, 3:02PM AEST - The Australian Stockmarket closes in 1 hour and 3 minutes.
To create a watchlist or portfolio of shares, Register

Sinovac Biotech Ltd. (SVA)

 8:00AM AEST: 6.42 USD  Up 0.07 (1.10%)  
 MORE ON SVA 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Sinovac Biotech, Ltd. (NGM:SVA) Delayed quote dataEdit
Last Trade:6.42 USD
Trade Time: 8:00AM AEST
Change:Up 0.07 (1.10%)
Prev Close:6.35
Open:6.47
Bid:6.16 x 500
Ask:6.68 x 500
1y Target Est:N/A
Day's Range:6.41 - 6.50
52wk Range:1.02 - 12.50
Volume:627,617
Avg Vol (3m):1,615,580
Market Cap:273.38M
P/E (ttm):20.38
EPS (ttm):0.32
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add SVA to Portfolio   Download Data

 HEADLINES 
•3 Reasons to Be Scared of These Stocks
at Motley Fool (Tue 3:05AM)
•Swine Flu Antiviral Helps BioCryst Crush Estimates in Q4
Indie Research (Fri, Feb 5)
•Sinovac Announces Closing of Common Share Offering
PR Newswire (Wed, Feb 3)
•Sinovac Announces Exercise of Over-Allotment Option
PR Newswire (Tue, Feb 2)
•China Biotech in Review: More Money Raised in China IPOs in 2009 than in the U.S.
at Seeking Alpha (Mon, Feb 1)
•Sinovac's Secondary Offering Will Help Fund Acquisitions
at Seeking Alpha (Fri, Jan 29)
•Sinovac Biotech increases size of stock offering
AP (Thu, Jan 28)
•Sinovac Announces Upsizing and Pricing of Common Share Offering
PR Newswire (Thu, Jan 28)
•China Biotech Week in Review: China Pharma Investment, Company Progress
at Seeking Alpha (Mon, Jan 25)
•Early-Market Movers: SunOpta, Sinovac Biotech
at Fox Business (Fri, Jan 22)
•Sinovac Issues 2009 Guidance, Announces Secondary Stock Issue
at Seeking Alpha (Fri, Jan 22)
•Sinovac Announces Plan to Launch Offering of Common Shares
PR Newswire (Thu, Jan 21)
•Sinovac Announces Recent Developments
PR Newswire (Thu, Jan 21)
•The Next Million-Dollar Penny Stock
at Motley Fool (Thu, Jan 21)
More Headlines for SVA...
 ANALYST 
EPS Est (next year) () :N/A
EPS Est (in 2 years) () :N/A
Avg Rec (current)*:N/A
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Sinovac Biotech Ltd., a biopharmaceutical company, focuses on the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases in China.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
•Latest News•7 Indices